HopeStage
Back to all studies
CompletedNCT02456454

Valproate Compared With Risperidone for Bipolarity in Young Children

About this title

Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder

Read the official source — NCT02456454

Researchers compared Risperidone, Valproic Acid and placebo to find out how the approaches affected manic symptoms in children with bipolarity.

Medication studyAges 3–7
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Risperidone, Valproic Acid and placebo to find out how the approaches affected manic symptoms in children with bipolarity.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 3 years to 7 years. Other eligibility criteria applied.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2006
Recruitment status
Completed
Enrollment listed in the registry
46
Sponsor
Nationwide Children's Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Not clearly listed
Age range
From 3 Years to 7 Years
Official registry ID
NCT02456454
Official title
Show the full official title

Placebo Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Risperidone, Valproic Acid and placebo to find out how the approaches affected manic symptoms in children with bipolarity.

Who is behind this study?

The study sponsor is Nationwide Children's Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Risperidone, Valproic Acid and Placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 3 years to 7 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies